This brand name is authorized in Malta, United Kingdom
The drug NEOMAG contains one active pharmaceutical ingredient (API):
|
1
Magnesium glycerophosphate
UNII 9WK0PNY0VU - MAGNESIUM GLYCEROPHOSPHATE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A12CC | Magnesium | A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: MT | Medicines Authority | Identifier(s): AA565/52701, AA729/24101 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
